Easy to dispense. Easy for patients to get right every time.

Each TussiCaps^® capsule contains an accurate, consistent dose of hydrocodone and chlorpheniramine.

TussiCaps^® is available in two-dose strengths:

• 10 mg/8 mg (Adults and children 12 years of age and older)
• 5 mg/4 mg (children 6-11 years of age)

There is no AB-rated generic equivalent to TussiCaps^®.

Description of capsule—10 mg/8mg dose:

TussiCaps^® comes in the form of a capsule featuring the following markings:

• A capital M set in a box ()
• The abbreviation HP/CP (hydrocodone polistirex/chlorpheniramine polistirex)
• 10 mg/8 mg

Description of capsule—5 mg/4mg dose:

TussiCaps^® comes in the form of a capsule featuring the following markings:

• A capital M set in a box ()
• The abbreviation HP/CP (hydrocodone polistirex/chlorpheniramine polistirex)
• 5 mg/4 mg

Packaging:

10 mg/8 mg dose: Available in convenient 20-count and 100-count packaging—avoids the inconvenience of multidose glass bottles.

5 mg/4 mg dose: Available in 100-count packaging—avoids the inconvenience of multidose glass bottles.

IMPORTANT RISK INFORMATION
TussiCaps^® (hydrocodone polistirex and chlorpheniramine polistirex) extended-release capsules are indicated for relief of cough and upper respiratory symptoms associated with allergy or cold in adults and children 6 years of age and older. TussiCaps is contraindicated in children under 6 years of age.

TussiCaps^® is contraindicated in the presence of known allergy or sensitivity to hydrocodone or chlorpheniramine. The most common adverse reactions associated with TussiCaps^® are sedation, drowsiness, and mental clouding, which may impair the mental and/or physical abilities required for potentially hazardous tasks. Overdose with hydrocodone-containing products has been associated with fatal respiratory depression. Benefit to risk ratio should be carefully considered especially in pediatric patients with respiratory embarrassment.